Avoro Capital Advisors LLC Xenon Pharmaceuticals Inc. Transaction History
Avoro Capital Advisors LLC
- $6.86 Billion
- Q4 2024
A detailed history of Avoro Capital Advisors LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 5,666,666 shares of XENE stock, worth $223 Million. This represents 3.24% of its overall portfolio holdings.
Number of Shares
5,666,666
Previous 5,666,666
-0.0%
Holding current value
$223 Million
Previous $223 Million
0.38%
% of portfolio
3.24%
Previous 3.36%
Shares
9 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
70.4MCall Options Held
109KPut Options Held
2.1K-
Driehaus Capital Management LLC Chicago, IL4.52MShares$178 Million1.73% of portfolio
-
Wellington Management Group LLP Boston, MA3.78MShares$149 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$115 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$113 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$108 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.45B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...